Regulation of interleukin (IL)-1β gene transcription induced by IL-1β in rheumatoid synovial fibroblast-like cells, E11, transformed with simian virus 40 large T antigen

Journal of Rheumatology

Volumn 24, Issue 3, 1997, Pages 420-429

  Abe, Mihoko ^a,b   Mihoko, A ^b   Tanaka, Yoshiya ^a,b   Saito, Kazuyoshi ^a   Shirakawa, Fumihiko ^a,b   Koyama, Yoshinobu ^a   Goto, Sadao ^a,b   Eto, Sumiya ^a,b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Department of Internal Medicine ^*

Author keywords

AP 1; fibroblasts; interleukin 1; nuclear factor B; nuclear factors; rheumatoid arthritis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NUCLEAR FACTOR I;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; ARTHRITIS, RHEUMATOID; CELL DIVISION; CELL TRANSFORMATION, VIRAL; CLONE CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; NF-KAPPA B; RNA, MESSENGER; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 1842301049     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Trang LE, Granstrom E, Lovgren O: Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. Scand J Rheumatol 1977;6:151-4.
2. Klickstein LB, Shapleigh C, Goetzl EJ: Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest 1980;66:1166-70.
3. Davidson EM, Rae SA, Smith MJ: Leukotriene B4 in synovial fluid. J Pharm Pharmacol 1982;34:410.
4. Bombardieri S, Cattani P, Ciabattoni G, et al: The synovial prostaglandin system in chronic inflammatory arthritis: Differential effects of steroidal and nonsteroidal anti-inflammatory drugs. Br J Pharmacol 1981;73:893-901.
5. Gravallese EM, Darling JM, Ladd AL, et al: In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 1991;34:1076-84.
6. Hasty KA, Reife RA, Kang AH, Stuart JM: The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum 1990;33:388-97.
7. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI: Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 1990;265:17238-45.
8. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H: Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): Correlation with rheumatoid arthritis. Ann Rheum Dis 1989;48:645-53.
9. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW: Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992;35:35-42.
10. Hopkins SJ, Humphreys M, Jayson MI: Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 1988;12:422-1.
11. Wood DD, Ihrie EJ, Dinarello CA, Cohen PL: Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum 1983;26:975-83.
12. Nouri AM, Panayi GS, Goodman SM: Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol 1984;55:295-302.
13. Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA: Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986;11:645-8.
14. Miossec P, Dinarello CA, Ziff M: Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum 1986;29:461-70.
15. Dayer JM, Beutler B, Cerami A: Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-8.
16. Saxne T, Palladino MJ, Heinegard D, Talal N, Wollheim FA: Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
17. Houssiau FA, Devogelaer JP, Van Damme J, Nagant de Deuxchaisnes E, Van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988;31:784-8.
18. Waage A, Kaufmann C, Espevik T, Husby G: Interleukin-6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol 1989;50:394-8.
19. Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M: Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 1989;83:585-92.
20. Hirano T, Matsuda T, Turner M, et al: Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 1988;18:1797-801.
21. Tan PL, Farmiloe S, Yeoman S, Watson JD: Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts. J Rheumatol 1990;17:1608-12.
22. Fava R, Olsen N, Keski OJ, Moses H, Pincus T: Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med 1989;169:291-6.
23. Lafyatis R, Thompson NL, Remmers EF, et al: Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization. J Immunol 1989;143:1142-8.
24. Postlethwaite AE, Keski OJ, Moses HL, Kang AH: Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 1987;165:251-6.
25. Waring PM, Carroll GJ, Kandiah DA, Buirski G, Metcalf D: Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1993;36:911-5.
26. Hamilton JA, Waring PM, Filonzi EL: Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha. J Immunol 1993;150:1496-502.
27. Villiger PM, Geng Y, Lotz M: Induction of cytokine expression by leukemia inhibitory factor. J Clin Invest 1993;91:1575-81.
28. Xu WD, Firestein GS, Taetle R, Kaushansky K, Zvaifler NJ: Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest 1989;83:876-82.
29. Alvaro GJ, Zvaifler NJ, Firestein GS: Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: A possible role in rheumatoid arthritis. J Exp Med 1989;170:865-75.
30. Mauviel A, Temime N, Charron D, Loyau G, Pujol JP: Induction of interleukin-1 beta production in human dermal fibroblasts by interleukin-1 alpha and tumor necrosis factor-alpha. Involvement of protein kinase-dependent and adenylate cyclase-dependent regulatory pathways. J Cell Biochem 1991;41:174-83.
31. Tanaka Y, Albelda SM, Horgan KJ, et al: CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J Exp Med 1992;176:245-53.
32. Clark BD, Collins KL, Gandy MS, Webb AC, Auron PE: Genomic sequence for human prointerleukin 1 beta: Possible evolution from a reverse transcribed prointerleukin 1 alpha gene [published erratum appears in Nucleic Acids Res 1987;15:868]. Nucleic Acids Res 1986;14:7897-914.
33. Laimins LA, Gruss P, Pozzatti R, Khoury G: Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus. J Virol 1984;49:183-9.
34. Lenardo M, Rustgi AK, Schievella AR, Bernards R: Suppression of MHC class I gene expression by N-myc through enhancer inactivation. Embo J 1989;8:3351-5.
35. Shirakawa F, Saito K, Bonagura CA, et al: The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol Cell Biol 1993;13:1332-44.
36. Sleigh MJ: A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells. Anal Biochem 1986;156:251-6.
37. Moore M, Teresky AK, Levine AJ, Seiberg M: p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice. J Virol 1992;66:641-9.
38. Inoue H, Kondoh G, Sudiro TM, Hakura A: Stability of p53 protein in rat cells transformed by various viral transforming genes. Virology 1992;187:343-7.
39. Lin JY, Simmons DT: The ability of large T antigen to complex with p53 is necessary for the increased life span and partial transformation of human cells by simian virus 40. J Virol 1991;65:6447-53.
40. Fenton MJ, Clark BD, Collins KL, Webb AC, Rich A, Auron PE: Transcriptional regulation of the human prointerleukin 1 beta gene. J Immunol 1987;138:3972-9.
41. Lin JX, Vilcek J: Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. J Biol Chem 1987;262:11908-11.
42. McKean DJ, Bell M, Huntoon C, et al: IL-1 receptor and TCR signals synergize to activate NF-kappa B-mediated gene transcription. Int Immunol 1995;7:9-20.
43. Williams DH, Jeffery LJ, Murray EJ: Aurothioglucose inhibits induced NF-KB and AP-1 activity by acting as an IL-1 functional antagonist. Biochim Biophys Acta 1992;1180:9-14.
44. Tsukada J, Saito K, Waterman WR, Webb AC, Auron PE: Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 beta gene. Mol Cell Biol 1994;14:7285-97.
45. Buras JA, Monks BG, Fenton MJ: The NF-beta A-binding element, not an overlapping NF-IL-6 binding element, is required for maximal IL-1 beta gene expression. J Immunol 1994;152:4444-54.
46. Bensi G, Mora M, Raugei G, Buonamassa DT, Rossini M, Melli M: An inducible enhancer controls the expression of the human interleukin 1 beta gene. Cell Growth Differ 1990;1:491-7.
47. Gray JG, Chandra G, Clay WC, et al: A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin 1 beta gene is necessary for induction in U937 and THP-1 monocytic cell lines. Mol Cell Biol 1993;13:6678-89.
48. Stein B, Baldwin AJ, Ballard DW, Greene WC, Angel P, Herrlich P: Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. Embo J 1993;12:3879-91.
49. Lan Q, Mercurius KO, Davies PF: Stimulation of transcription factors NF kappa B and API in endothelial cells subjected to shear stress. Biochem Biophys Res Commun 1994;201:950-6.
50. Klampfer L, Lee TH, Hsu W, Vilcek J, Chen KS: NF-IL6 and AP-1 cooperatively modulate the activation of the TSG-6 gene by tumor necrosis factor alpha and interleukin 1. Mol Cell Biol 1994;14:6561-9.
51. Angel P, Allegretto EA, Okino ST, et al: Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 1988;332:166-71.
52. Bohmann D, Bos TJ, Admon A, Nishimura T, Vogt PK, Tjian R: Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 1987;238:1386-92.
53. Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M: The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 1988;54:541-52.
54. Curran T, Franza BJ: Fos and Jun: The AP-1 connection. Cell 1988;55:395-7.
55. Angel P, Karin M: The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1991;1072:129-57.
56. Cullen BR: Regulation of HIV-1 gene expression. Faseb J 1991;5:2361-8.
57. Chinnadurai G: Modulation of HIV-enhancer activity by heterologous agents: A minireview. Gene 1991;101:165-70.
58. Staal FJ, Roederer M, Herzenberg LA, Herzenberg LA: Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87:9943-7.
59. Urban MB, Schreck R, Baeuerle PA: NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. Embo J 1991;10:1817-25.
60. Lernbecher T, Muller U, Wirth T: Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 1993;365:767-70.
61. Ganchi PA, Sun SC, Greene WC, Ballard DW: A novel NF-kappa B complex containing p65 homodimers: Implications for transcriptional control at the level of subunit dimerization. Mol Cell Biol 1993;13:7826-35.
62. Roebuck KA, Rahman A, Lakshminarayanan V, Janakidevi K, Malik AB: H202 and tumor necrosis factor-alpha activate intercellular adhesion molecule I (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J Biol Chem 1995;270:18966-74.